P.V. MAKAROV¹, I.E. KRAVCHENKO²

 ¹Tver State Medical University, Tver

²Kazan State Medical University, Kazan

 Contact details:

Makarov P.V. — postgraduate student of the Department of Infectious Diseases and Epidemiology

Address: 4 Sovetskaya St., Tver, Russian Federation, 170100, tel.: +7-904-023-13-25, e-mail: global-create@yandex.ru

Under the ongoing epidemic of HIV-infection, the incidence of tuberculosis continues to grow without a visible tendency to decrease. It is necessary to improve treatment approaches that allow more flexibility in determining the effectiveness of antiretroviral therapy (ART) at the very beginning of treatment for HIV / tuberculosis coinfection. Lipids play an important role in the formation of a tuberculous lesion. The study of the total lipids dynamics in HIV/tuberculosis coinfection has the potential for an early assessment of the ART effectiveness.

The purpose is to evaluate the effectiveness of the course of antiretroviral therapy in patients with HIV / tuberculosis at 4B stage based on the values of total serum lipids.

Material and methods. The study included 300 patients with HIV / tuberculosis, of which 100 patients received only tuberculosis chemotherapy, 100 patients received ART and 1 TB therapy regimen (TBT), 100 patients received ART and 4 TBT regimen. Clinical and laboratory parameters were studied in all patients, the blood serum lipid spectrum was analyzed (total lipids (OL), total phospholipids (OFL), free cholesterol (CX), cholesterol esters (EH), triglycerides (TG), free fatty acids (FFA)) and the effectiveness of the ART was evaluated. To detect early changes in total lipids, the results were analyzed after 1 month.

Results. It was found that ART in HIV/tuberculosis patients causes significant positive changes in the metabolism of total lipids (OL, OFL, CX, EH, TG, FFA), largely bringing their values closer to the level of healthy individuals, which is accompanied by a pronounced clinical and radiological effect in the form of more frequent abacylation. Against the background of ART, an inflammatory immunity restoration syndrome (IIRS) developed, which was stopped by pathogenetic therapy.

Key words: HIV-infection, tuberculosis, antiretroviral therapy, anti-tuberculosis therapy, cholesterol, lipids.

REFERENCES

1. Krasnova E.I., Khokhlova N.I., Provorova V.V. et al. Analysis of epidemiological data on HIV infection at the present stage. Journal of Siberian Medical Sciences, 2018, no. 1, pp. 84–95 (in Russ.).
2. Kirzhanova V.V., Grigorova N.I., Bobkov E.N. et al. Deyatel’nost’ narkologicheskoy sluzhby v Rossiyskoy Federatsii v 2019–2020 gg.: analiticheskiy obzor [Activities of the Narcological Service in the Russian Federation in 2019–2020: An Analytical Review]. Moscow: FGBU «NMITs PN im. V.P. Serbskogo», MZ RF, 2021, available athttp://nncn.serbsky.ru/wp-content/uploads/2021/12/2.NarkologicheskayaSluzhbaRF-AO2019-2020.pdf
3. Mel’nikova E.N., Marchenko A.N., Kondratova S.E. et al. Analysis of the features of the development of the epidemic situation of HIV infection in the Tyumen region. Ural’skiy meditsinskiy zhurnal, 2020, no. 4 (187), pp. 101–104 (in Russ.). DOI: 10.25694/URMJ.2020.04.16
4. Borodulina E.A., Vdoushkina E.S., In’kova A.T. Pulmonary tuberculosis in patients with HIV infection. Vrach, 2020, no. 31 (1), pp. 37–43 (in Russ.). DOI: 10.29296/25877305-2020-01-07
5. Vsemirnaya organizatsiya zdravookhraneniya. Tuberkulez. Osnovnye fakty, 2020 [World Health Organization. Tuberculosis. Basic facts. 2020], avaialble at: https://www.who.int/ru/news-room/fact-sheets/detail/tuberculosis
6. Azovtseva O.V., Gritsyuk A.V., Gemaeva M.D. et al. HIV infection and tuberculosis as the most difficult variant of comorbidity. Vestnik Novgorodskogo gosudarstvennogo universiteta, 2020, no. 1 (117), pp. 79–84 (in Russ.). DOI: 10.34680/2076-8052.2020.1(117).79-84
7. Voznesenskiy S.L., Petrova E.V., Kozhevnikova G.M. et al. Analysis of the effectiveness of antiretroviral therapy in patients in the intensive care unit. Infektsionnye bolezni: novosti, mneniya, obuchenie, 2021, no. 4 (10), pp. 59–65 (in Russ.). DOI: 10.33029/2305-3496-2021-10-4-59-65
8. Puzyreva L.V., Mordyk A.V., Rudenko S.A. Genitourinary tuberculosis in the structure of morphological findings in those who died in the late stages of HIV infection. Vestnik urologii, 2021, no. 9 (1), pp. 64–71. DOI: 10.21886/2308-6424-2021-9-1-64-71
9. Kaminskaya G.O., Abdullaev R.Yu. Tuberculosis and lipid metabolism. Tuberkulez i bolezni legkikh, 2016, no. 6, pp. 53–63 (in Russ.).
10. Pokrovskiy V.V., Yurin O.G., Kravchenko A.V. et al. National recommendations for dispensary observation and treatment of patients with HIV infection 2017. Clinical protocol. Epidemiologiya i infektsionnye bolezni. Aktual’nye voprosy, 2017, no. 6, suppl. 80 p (in Russ.).
11. Ryasenskiy D.S., Aseev A.V., El’gali A.I. Influence of glycyrrhizic acid on the state of membrane structures of mononuclear cells in patients with pulmonary tuberculosis on the background of anti-tuberculosis chemotherapy. Tuberkulez i bolezni legkikh, 2018, no. 96 (10), pp. 35-40 (in Russ.). DOI: 10.21292/2075-1230-2018-96-10-35-40
12. Prikaz MZ RF ot 29.12.2014 no. 951 «Ob utverzhdenii metodicheskikh rekomendatsiy po sovershenstvovaniyu diagnostiki i lecheniya tuberkuleza organov dykhaniya» [Order of the Ministry of Health of the Russian Federation of December 29, 2014 No. 951 “On approval of guidelines for improving the diagnosis and treatment of respiratory tuberculosis”], available at: https://docs.cntd.ru/document/420248060